Pharmaceutical formulation
US12257218B2 · kind B2 · utility
0Cited by
134References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2022 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Feb 14, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.